We use cookies to give you the best possible experience. If you continue, we’ll assume you are happy to receive the cookies we place. Privacy and cookies information.
News
-
Swallowing Awareness Day 2019
12 March 2019
Wednesday 13 March 2019 is Swallowing Awareness Day, and here at The Royal Marsden our speech and language therapists share their expertise on a daily basis, helping head and neck patients pre and post treatment.
Read more -
CANCELLED: The Banham Marsden March
9 March 2019
It is with great regret that we have cancelled The Banham Marsden March, due to take place tomorrow, due to a yellow weather warning issued by the Met Office for high wind speeds.
Read more -
World Cancer Day 2019- Early Diagnosis
4 February 2019
This World Cancer day, we're focusing on how advancements in early diagnosis are making a difference to cancer patients everywhere.
Read more -
Professor Martin Gore CBE
10 January 2019
Read more -
Targeted drug slows tumour growth in patients with early breast cancer
6 December 2018
Adding a new targeted therapy to hormone therapy halts the growth of tumour cells in women with early-stage breast cancer, new research shows.
Read more -
Professor Ian Smith awarded the William L. McGuire Memorial Lecture Award
5 December 2018
Consultant Medical Oncologist Professor Ian Smith has won the 2018 William L. McGuire Memorial Lecture Award for his lifelong work in breast cancer oncology.
Read more -
Immunotherapy keeps some patients with advanced head and neck cancer alive for more than three years
30 November 2018
A new immunotherapy can greatly extend the lives of a proportion of people with advanced head and neck cancer, with some living for three years or more, a major new clinical trial reports.
Read more -
North London genomics laboratory hub announced
29 November 2018
The Royal Marsden NHS Foundation Trust has been announced as the lead for genomic cancer testing in one of seven new genomics laboratory hubs.
Read more -
Maggie’s at The Royal Marsden
19 November 2018
The Royal Marsden in Sutton and Maggie’s, the charity that provides free practical, emotional and social support to people with cancer and their family and friends, today celebrated a key milestone in the construction of a new Maggie’s centre
Read more -
“Landmark results” in key ovarian cancer research
22 October 2018
Results from a Phase III trial have demonstrated that lynparza (olaparib) therapy could cut the risk of disease progression or death by 70% in patients with newly-diagnosed, advanced BRCA mutated ovarian cancer.
Read more